Top

Published in:

Open Access 01-10-2009 | Educational Feature

Treatment of hypertension in children and adolescents

Authors: Marc B. Lande, Joseph T. Flynn

Published in: Pediatric Nephrology | Issue 10/2009

Abstract

The treatment of hypertension in children and adolescents has been markedly changed in recent years by several factors, including the publication of new consensus recommendations, the obesity epidemic, and the increased availability of information on efficacy and safety of antihypertensive medications in the young. In this review we present an updated approach to the outpatient management of hypertension in the child or adolescent, utilizing representative cases to illustrate important principles as well as possible controversies.

Available only for authorised users

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc 289:2560–2572CrossRef

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2005) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. National heart, lung, and blood institute, Bethesda, Maryland. National institute of health, NIH publication 05:5267

Stergiou GS, Yiannes NJ, Rarra VC, Alamara CV (2005) White-coat hypertension and masked hypertension in children. Blood Press Monit 10:297–300PubMedCrossRef

Flynn JT, Daniels SR (2006) Pharmacologic treatment of hypertension in children and adolescents. J Pediatr 149:746–754PubMedCrossRef

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc 288:2981–2997CrossRef

Laos C, Metzl JD (2006) Performance-enhancing drug use in young athletes. Adolesc Med Clin 17:719–731PubMed

American Academy of Pediatrics, Committee on Sports Medicine and Fitness (1997) Adolescents and anabolic steroids: a subject review. Pediatrics 99:904–908CrossRef

Gaziano JM (2006) Nonnarcotic analgesics and hypertension. Am J Cardiol 97 [Suppl]:10E–16ECrossRef

Chasan-Taber L, Willett WC, Manson JE, Spiegelman D, Hunter DJ, Curhan G, Colditz GA, Stampfer MJ (1996) Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 94:483–489PubMedCrossRef

10.

Paridon SM, Alpert BS, Boas SR, Cabrera ME, Caldarera LL, Daniels SR, Kimball TR, Knilans TK, Nixon PA, Rhodes J, Yetman AT (2006) Clinical stress testing in the pediatric age group: a statement from the American Heart Association Council on Cardiovascular Disease in the Young, Committee on Atherosclerosis, Hypertension, and Obesity in Youth. Circulation 113:1905–1920PubMedCrossRef

11.

Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA (2004) American College of Sports Medicine Position Stand: exercise and hypertension. Med Sci Sports Exerc 36:533–553PubMedCrossRef

12.

Kaplan NM, Gidding SS, Pickering TG, Wright JT (2005) Task force 5: systemic hypertension. J Am Coll Cardiol 45:1346–1348PubMedCrossRef

13.

Mitchell JH, Haskell W, Snell P, Van Camp SP (2005) Task Force 8: classification of sports. J Am Coll Cardiol 45:1364–1367PubMedCrossRef

14.

Alpert BS (2000) Exercise as a therapy to control hypertension in children. Int J Sports Med 21[suppl 2]:S 94–S 97CrossRef

15.

Liebson PR, Devereux RB, Horan MJ (1987) Hypertension research: echocardiography in the measurement of left ventricular wall mass. Hypertension 9(2 Pt 2):II-2–II-5

16.

Sachtleben T, Fields KB (2003) Hypertension in the athlete. Curr Sports Med Rep 2:79–83PubMedCrossRef

17.

Maron BJ (2000) The paradox of exercise. N Engl J Med 343:1409–1411PubMedCrossRef

18.

Maron BJ (2003) Sudden death in young athletes. N Engl J Med 349:1064–1075PubMedCrossRef

19.

Alpert BS (1999) Exercise in hypertensive children and adolescents: any harm done? Pediatr Cardiol 20:66–69PubMedCrossRef

20.

American Academy of Pediatrics, Committee on Sports Medicine and Fitness (1997) Athletic participation by children and adolescents who have systemic hypertension. Pediatrics 99:637–638CrossRef

21.

Cava JR, Danduran MJ, Fedderly RT, Sayger PL (2004) Exercise recommendations and risk factors for sudden cardiac death. Pediatr Clin North Am 51:1401–1420PubMedCrossRef

22.

Haykowsky MJ, Findlay JM, Ignaszewski AP (1996) Aneurysmal subarachnoid hemorrhage associated with weight training: three case reports. Clin J Sport Med 6:52–55PubMedCrossRef

23.

Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Eng J Med 354:2443–2451CrossRef

24.

Schaefer C (2003) Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Birth Defects Res A Clin Mol Teratol 67:591–594PubMedCrossRef

25.

North American Pediatric Renal Trials and Collaborative Studies 2006 Annual Report. Available at: https://doi.org/web.emmes.com/study/ped/annlrept/annlrept2006.pdf

26.

Fivush BA, Jabs K, Neu AM, Sullivan EK, Feld L, Kohaut E, Fine R (1998) Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS. North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 12:328–337PubMedCrossRef

27.

Flynn J, Pierce C, Mitsnefes M, Cole S, Parekh R, Saland J, Blydt-Hansen T, Furth S, Warady B (2007) Blood pressure (BP) in children with chronic kidney disease (CKD): preliminary findings from the chronic kidney disease in children (CKiD) cohort study (abstract). E-PAS 2007:61:7920.4 Available at: https://doi.org/www.abstracts2view.com/pas

28.

Mitsnefes MM, Kimball TR, Daniels SR (2003) Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol 18:145–149CrossRefPubMed

29.

Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT Jr (1998) Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32:853–906PubMedCrossRef

30.

Flynn JT (2006) Cardiovascular disease in children with chronic renal failure. Growth Horm IGF Res 16:S84–S90PubMedCrossRef

31.

Kidney Disease Outcomes Quality Initiative (K/DOQI) (2004) Clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43 [5 Suppl 1]:S42–S64

32.

Parekh RS, Carroll CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191–197PubMedCrossRef

33.

Chavers BM, Li S, Collins AJ, Herzog CA (2002) Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 62:648–653PubMedCrossRef

34.

Chavers BM, Herzog CA (2004) The spectrum of cardiovascular disease in children with predialysis chronic kidney disease. Adv Chronic Kidney Dis 11:319–327PubMedCrossRef

35.

Mitsnefes MM (2006) Cardiovascular complications of pediatric chronic kidney disease. Pediatr Nephrol DOI https://doi.org/10.1007/s00467-006-0359-0 PubMedCrossRef

36.

Peterson JC, Adler S, Burkart JM, Greene T, Herbert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter LJ (1995) Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754–762PubMedCrossRef

37.

Mitsnefes M, Ho PL, McEnery PT (2003) Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol 14:2618–2622CrossRefPubMed

38.

Shatat IF, Flynn JT (2005) Hypertension in children with chronic kidney disease. Adv Chronic Kidney Dis 12:378–384PubMedCrossRef

39.

Wuhl E, Mehls O, Schaefer F, ESCAPE Trial Group (2004) Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66:768–776PubMedCrossRef

40.

Ellis D, Moritz ML, Vats A, Janosky JE (2004) Antihypertensive and renoprotective efficacy and safety of losartan; a long-term study in children with renal disorders. Am J Hypertens 17:928–935PubMed

41.

Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T (2003) Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomized controlled trial. Lancet 361:117–124CrossRefPubMed

42.

Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM (2001) Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis 38:18–25PubMedCrossRef

43.

Ellis D (2002) Combined use of enalapril and losartan to reduce proteinuria: a question of safety. Am J Kidney Dis 39:209–211PubMedCrossRef

44.

Sarafidis PA, Khosla N, Bakris GL (2007) Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis 49:12–26PubMedCrossRef

45.

Kaito H, Nozu K, Iijima K, Nakanishi K, Yoshiya K, Kanda K, Przybyslaw Krol R, Yoshikawa N, Matsuo M (2006) The effect of aldosterone blockade in patients with Alport syndrome. Pediatr Nephrol 21:1824–1829PubMedCrossRef

46.

Gashti CN, Bakris GL (2004) The role of calcium antagonists in chronic kidney disease. Curr Opin Nephrol Hypertens 13:155–161PubMedCrossRef

47.

Woroniecki RP, Flynn JT (2005) How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists. Pediatr Nephrol 20:791–797CrossRefPubMed

48.

Centers for Disease Control and Prevention (2007). Overweight and obesity: childhood overweight: overweight prevalence. Available at: https://doi.org/www.cdc.gov/nccdphp/dnpa/obesity/childhood/prevalence.htm. Last accessed: June 26, 2007

49.

Speiser PW, Rudolf MC, Anhalt H, Camacho-Hubner C, Chiarelli F, Eliakim A, Freemark M, Gruters A, Hershkovitz E, Iughetti L, Krude H, Latzer Y, Lustig RH, Pescovitz OH, Pinhas-Hamiel O, Rogol AD, Shalitin S, Sultan C, Stein D, Vardi P, Werther GA, Zadik Z, Zuckerman-Levin N, Hochberg Z, Obesity Consensus Working Group (2005) Childhood obesity. J Clin Endocrinol Metab 90:1871–1887PubMedCrossRef

50.

Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ (2004) Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 113:475–482CrossRefPubMed

51.

Flynn JT (2005) Hypertension in childhood and adolescence. In: Kaplan NM (ed) Kaplan’s clinical hypertension, 9th edn. Lippincott-Williams and Wilkins, Philadelphia, PA, pp 465–488

52.

Landsberg L (2001) Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 19:523–528PubMedCrossRef

53.

Rocchini AP (2002) Obesity hypertension. Am J Hypertens 15(2 Pt 2):50S–52SPubMedCrossRef

54.

Rahmouni K, Haynes WG (2004) Leptin and the cardiovascular system. Recent Prog Horm Res 59:225–244PubMedCrossRef

55.

Sorof JM, Poffenbarger T, Franco K, Bernard L, Portman RJ (2002) Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr 140:660–666PubMedCrossRef

56.

Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, Mannarino E (2004) Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 43:1817–1822PubMedCrossRef

57.

Jones KL (2006) The dilemma of the metabolic syndrome in children and adolescents: disease or distraction? Pediatr Diabetes 7:311–321PubMedCrossRef

58.

Litwin M, Śladowska J, Antoniewicz J, Niemirska A, Wierzbicka A, Daszkowska J, Wawer ZT, Janas R, Grenda R (2007) Metabolic abnormalities, insulin resistance and metabolic syndrome in children with primary hypertension. Am J Hypertens 20:875–882PubMedCrossRef

59.

Monzavi R, Dreimane D, Geffner ME, Braun S, Conrad B, Klier M, Kaufman FR (2006) Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle intervention. Pediatrics 117:e1111–e1118PubMedCrossRef

60.

Chen AK, Roberts CK, Barnard RJ (2006) Effect of a short-term diet and exercise intervention on metabolic syndrome in overweight children. Metabolism 55:871–878PubMedCrossRef

61.

Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef

62.

Puri M, Flynn JT (2006) Management of hypertension in children and adolescents with the metabolic syndrome. J Cardiometab Syndr 1:259–268PubMedCrossRef

63.

Mason JM, Dickinson HO, Nicolson DJ, Campbell F, Ford GA, Williams B (2005) The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension. J Hypertens 23:1777–1781PubMedCrossRef

64.

Raitakari OT, Juonala M, Kahonen M, Taittonen L, Laitinen T, Maki-Torkko N, Jarvisalo MJ, Uhari M, Jokinen E, Ronnemaa T, Akerblom HK, Viikari JS (2003) Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. J Am Med Assoc 290:2277–2283CrossRef

65.

Flynn JT (2006) What is the significance of increased carotid intima media thickness in hypertensive adolescents? Hypertension 48:23–24PubMedCrossRef

Title: Treatment of hypertension in children and adolescents
Authors: Marc B. Lande
Joseph T. Flynn
Publication date: 01-10-2009
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 10/2009
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-007-0573-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Treatment of hypertension in children and adolescents

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2009

ACE gene insertion/deletion polymorphism and renal scarring in children with urinary tract infections

Persistent low albumin and temporary vascular access in pediatric patients with SLE on hemodialysis

Juvenile linear scleroderma with unique forms of renal involvement

Heat shock proteins in children and young adults on chronic hemodialysis

Successful thrombolysis of neonatal bilateral renal vein thrombosis originating in the IVC

Bilateral ureter stones in a 1-year-old boy